Funded by the National Institute for Health Research, RESPIRE is a Global Health Research Unit focusing on respiratory health in Asia.
- My personal and professional experiences with COVID-19 in Bangladesh | Dr Senjuti Saha
- Qualitative study explores the lived experience and attitudes towards chronic respiratory diseases in Vellore, India
- Stakeholder engagement in research projects during a pandemic
- Barriers to implementing asthma self-management in Malaysian primary care
- Seeking seamless depositing solutions for multi country (LMIC) qualitative data
The RESPIRE team includes partners from Bangladesh, India, Malaysia and Pakistan.
This programme of work focuses on infections, which start suddenly, such as pneumonia and bronchitis.
This programme of work focuses on long-term conditions which develop and worsen over time, including asthma, chronic obstructive lung disease (COPD) and lung cancer.
Launched in response to the coronavirus pandemic, this programme of work aims to accelerate research to build knowledge and inform the global response to COVID-19.
This platform will focus on how we work with partners to promote shared understanding and develop effective, reciprocal and ethical working relationships.
This platform will focus on increasing the number of health professionals and researchers who are trained to undertake high quality research.
This platform will focus on maximising the uses that research data can be put to, in safe and secure ways.